International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for …

F Bachelerie, A Ben-Baruch, AM Burkhardt… - Pharmacological …, 2014 - Elsevier
Sixteen years ago, the Nomenclature Committee of the International Union of Pharmacology
approved a system for naming human seven-transmembrane (7TM) G protein-coupled …

CCR4 and its ligands: from bench to bedside

O Yoshie, K Matsushima - International immunology, 2015 - academic.oup.com
Chemokines and chemokine receptors orchestrate cell migration and homing in the body.
Humans have at least 44 chemokines that are further classified into four subfamilies based …

The sentinel role of the airway epithelium in asthma pathogenesis

ST Holgate - Immunological reviews, 2011 - Wiley Online Library
The adoption of the concept that asthma is primarily a disease most frequently associated
with elaboration of T‐helper 2 (Th2)‐type inflammation has led to the widely held concept …

CC chemokine receptors and chronic inflammation—therapeutic opportunities and pharmacological challenges

GE White, AJ Iqbal, DR Greaves, CJ Garland - Pharmacological reviews, 2013 - Elsevier
Chemokines are a family of low molecular weight proteins with an essential role in leukocyte
trafficking during both homeostasis and inflammation. The CC class of chemokines consists …

Therapies for allergic inflammation: refining strategies to induce tolerance

CA Akdis - Nature medicine, 2012 - nature.com
Current therapies for asthma and allergy are relatively safe and effective at controlling
symptoms but do not change the chronic course of disease. There is no established method …

[HTML][HTML] International Union of Pharmacology. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical …

F Bachelerie, A Ben-Baruch, AM Burkhardt… - Pharmacological …, 2014 - ncbi.nlm.nih.gov
Sixteen years ago, the Nomenclature Committee of the International Union of Pharmacology
approved a system for naming human seven-transmembrane (7TM) G protein-coupled …

Severe asthma: advances in current management and future therapy

PJ Barnes - Journal of Allergy and Clinical Immunology, 2012 - Elsevier
Effective treatment of severe asthma is a major unmet need because patients' symptoms are
not controlled on maximum treatment with inhaled therapy. Asthma symptoms can be poorly …

G protein–coupled receptors in asthma therapy: pharmacology and drug action

SG Wendell, H Fan, C Zhang, PA Insel - Pharmacological reviews, 2020 - Elsevier
Asthma is a heterogeneous inflammatory disease of the airways that is associated with
airway hyperresponsiveness and airflow limitation. Although asthma was once simply …

Pathophysiology of asthma: what has our current understanding taught us about new therapeutic approaches?

ST Holgate - Journal of Allergy and Clinical Immunology, 2011 - Elsevier
Current asthma therapy is based on the use of adrenergic bronchodilator and anti-
inflammatory drugs the specificity, efficacy, duration of action, and safety of which have been …

The future of antibodies as cancer drugs

JM Reichert, E Dhimolea - Drug discovery today, 2012 - Elsevier
Targeted therapeutics such as monoclonal antibodies (mAbs) have proven successful as
cancer drugs. To profile products that could be marketed in the future, we examined the …